A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
Clinical trial NCT05458011 · COMPLETED
Trial details
- NCT number
- NCT05458011
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2024-01-31
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.